1. Granisetron: is there a dose–response effect on nausea and vomiting?

   • Masaru Minami

   Review 29 May 2003 Pages: 89 - 98

   

2. Modelling of ftorafur and 5-fluorouracil pharmacokinetics following oral UFT administration. A population study in 30 patients with advanced breast cancer

   • S. Urien
   • P. Fumoleau
   • R. Deporte-Fety

   Original Article 27 May 2003 Pages: 99 - 107

   

3. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics

   • Vinicius de Lima Vazquez
   • O. Anthony Stuart
   • Paul H. Sugarbaker

   Original Article 21 May 2003 Pages: 108 - 112

   

4. A retrospective evaluation of the feasibility of intrapatient dose escalation as appropriate methodology for dose-ranging studies for combination cytotoxic regimens

   • Sarah D. Jordan
   • Christopher J. Poole
   • Andrea Burton

   Original Article 29 May 2003 Pages: 113 - 118

   

5. A phase I trial of weekly paclitaxel, 13-cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies

   • A. Thalasila
   • Elizabeth Poplin
   • Robert S. DiPaola

   Original Article 24 May 2003 Pages: 119 - 124

   

6. Phase II study of biweekly irinotecan and mitomycin C combination therapy in patients with fluoropyrimidine-resistant advanced colorectal cancer

   • Yasuhide Yamada
   • Kuniaki Shirao
   • Atsushi Ohtsu

   Original Article 29 May 2003 Pages: 125 - 130

   

7. Effective combination of ET-743 and doxorubicin in sarcoma: preclinical studies

   • Daniela Meco
   • Tina Colombo
   • Riccardo Riccardi

   Original Article 29 May 2003 Pages: 131 - 138

   

8. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats

   • Steven M. Musser
   • Merrill J. Egorin
   • Julie L. Eiseman

   Original Article 22 May 2003 Pages: 139 - 146

   

9. Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study

   • Michela Donadio
   • Mara Ardine
   • Oscar Bertetto

   Original Article 23 May 2003 Pages: 147 - 152

10. Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study

    • Ross A. Soo
    • Hong L. Lim
    • Boon C. Goh

    Original Article 16 May 2003 Pages: 153 - 158

    

11. Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay

    • Daniel L. Gustafson
    • Michael E. Long
    • S. Gail Eckhardt

    Original Article 21 May 2003 Pages: 159 - 166

    

12. Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide

    • Patricia E. Schroeder
    • Peter Buhl Jensen
    • Brian B. Hasinoff

    Original Article 15 May 2003 Pages: 167 - 174